Novan Inc (NOVN)

NASDAQ
4.97
+0.19(+3.97%)
Pre Market
4.96
-0.01(-0.20%)
- Real-time Data
  • Volume:
    236,205
  • Bid/Ask:
    4.72/5.00
  • Day's Range:
    4.71 - 5.00

NOVN Overview

Prev. Close
4.78
Day's Range
4.71-5
Revenue
3.38M
Open
4.83
52 wk Range
4.71-25.9
EPS
-1.79
Volume
236,205
Market Cap
93.51M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
326,508
P/E Ratio
-
Beta
-0.02
1-Year Change
-3.48%
Shares Outstanding
18,815,892
Next Earnings Date
Mar 30, 2022
What is your sentiment on Novan Inc?
or
Market is currently closed. Voting is open during market hours.

Novan Inc Company Profile

Employees
23

Novan, Inc., a clinical development-stage biotechnology company, provides nitric oxide-based therapies to treat dermatological and oncovirus-mediated diseases. Its clinical stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical anti-viral gel for the treatment of viral skin infections; SB208, a topical broad-spectrum anti-fungal gel for the treatment of fungal infections of the skin and nails, including athlete’s foot and fungal nail infections; and SB414, a topical cream-based gel product candidate for the treatment of inflammatory skin diseases. The company also develops SB207, an anti-viral product candidate for the treatment of external genital warts; WH602, a nitric oxide-containing intravaginal gel to treat high-risk human papilloma virus (HPV); WH504, a non-gel formulation product candidate to treat high-risk HPV; and SB019 for the treatment of SARS-CoV-2. Novan, Inc. has a license agreement with Sato Pharmaceutical Co., Ltd.; and a strategic alliance with Orion Corporation. The company was incorporated in 2006 and is based in Durham, North Carolina.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyNeutralNeutralStrong SellSell
Technical IndicatorsStrong BuyStrong BuyBuyStrong SellSell
SummaryStrong BuyBuyNeutralStrong SellSell
  • .... 5.51?
    0
    • ha,,,ha....ha.....is 79sen
      0
      • go to 79$ 🚀🚀🚀🚀
        0
        • Why?
          0
      • no.....no.....no.....
        0
        • This a typical Example of a company Board to choose incompetent CEOs.Great company bad management and leadership.
          1
          • https://finance.yahoo.com/news/novan-announces-closing-40-million-200100356.html
            0
            • It seems going down to 3 since the company selling
              1
              • Hold..Hold Soon 25
                2
                • Hold..hold…
                  2
                  • bulls you have not seen anything yet the stock returned to where it was before the RS the big rise starts on Monday good luck to all
                    3
                    • I see most likely back to 1.5 $
                      0
                  • plz hel first day
                    0
                    • bring them gains to AMC. It's going to be epic
                      0
                      • bring them gains to AMC. It's going to be epic
                        0
                        • Roth Capital Adjusts Novan PT to $40 From $26,
                          0
                          • Will🚀🚀🚀🚀
                            0
                            • resistance at 16
                              1
                              • it is now starting to grow today
                                0
                                • explain more
                                  0
                                • where do you know from?
                                  0
                              • it is just a dip
                                1
                                • What do you mean?
                                  0
                                • Andrea Karin i mean it might bounce again
                                  1
                                • and go higher with each bounce?
                                  0
                              • The increase is due to the approval of cream to treat infectious skin diseases.very volatile stock.
                                0
                                • Its not the approval, its the good results of the cream so far, approval happens after its run through the FDA
                                  0
                              • Shouldnt have a problem getting to 20+ today!
                                1
                                • how? it is going down
                                  0
                              • what is the reason for increase in this stock?
                                0
                                • Victoria Monserratshoud i buy now?
                                  0
                                • no to late bro
                                  0
                                • Good results on the cream
                                  0
                              • it will go today till 25
                                0
                                • Novan end of summer $100
                                  2
                                  • aham... 😏
                                    1
                                • http://investors.novan.com/news-releases/news-release-details/novan-reports-positive-topline-results-pivotal-phase-3-trial
                                  0
                                  • Novan announces "positive" preclinical results with berdazimer sodium in a SARS-CoV-2 transmission model in golden Syrian hamsters June 10, 2021 08:34 AM ET Briefing.com Related Investments: Novan Inc Data indicate that berdazimer sodium prevents progression of SARS-CoV-2 infection in two independent in vivo transmission studies.Statistically significant, dose-dependent reduction in the amount of virus in the lung with doses as low as 2 mg/mL. Preliminary toxicology and pharmacology study results suggest intranasal administration is well-tolerated and safe.In light of these promising results, the Company is exploring opportunities to develop an anti-viral therapy against COVID-19, the disease caused by the SARS-CoV-2 virus, both internally and potentially through strategic partnerships for this program.
                                    0
                                    • Why they split, may still go down, but two analysts think is is worth over #20 FI you get approval.
                                      0
                                  Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                  Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.